Center for Scientific Review; Notice of Closed Meetings, 71371-71372 [2023-22769]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Alzheimer’s Disease and its Related
Dementias.
Date: November 8–9, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J,
Bethesda, MD 20892, (301) 435–1042,
zakam2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Motor System, Pain, and Olfaction.
Date: November 8, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Myalgic
Encephalomyelitis-Chronic Fatigue
Syndrome.
Date: November 8, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Roger Janz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8515, janzr2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 11, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–22770 Filed 10–13–23; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
17:03 Oct 13, 2023
Jkt 262001
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA/
REAP: Musculoskeletal, Oral, and Skin
Sciences.
Date: November 7, 2023.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Musculoskeletal, Rehabilitation
and Skin Sciences.
Date: November 7–8, 2023.
Time: 1:30 p.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Chemistry, Biochemistry and
Biophysics.
Date: November 8–9, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Pantazatos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–2381, dennis.pantazatos@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodevelopment and Plasticity.
Date: November 9, 2023.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
71371
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vanessa S. Boyce, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 4185,
MSC 7850, Bethesda, MD 20892, (301) 402–
3726, boycevs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Research
Enhancement Awards: Molecular Genetics,
Cellular & Cancer Biology.
Date: November 13, 2023.
Time: 1:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian Paul Chadwick,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3586, chadwickbp@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Psychopathology.
Date: November 13, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stephanie Christine Nagle
Emmens, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 594–6604,
nagleemmenssc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Cell Biology, Developmental
Biology, and Bioengineering.
Date: November 14, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196,
MSC 7812, Bethesda, MD 20892, 301–435–
2902, gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery for Aging,
Neurodegenerative and Neurological
Disorders.
Date: November 16–17, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Kathryn Partlow, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1016D,
E:\FR\FM\16OCN1.SGM
16OCN1
71372
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices
Bethesda, MD 20892, (301) 594–2138,
partlowkc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery Involving the
Nervous System.
Date: November 16–17, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lai Yee Leung, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011D,
Bethesda, MD 20892, (301) 827–8106,
leungl2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 11, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–22769 Filed 10–13–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Request for Information; Potential
Changes to its Evidence-Based
Practices Resource Center; Notice of
Correction
Substance Abuse and Mental
Health Services Administration, HHS.
AGENCY:
ACTION:
Notice; correction.
The Substance Abuse and
Mental Health Services Administration
published a document in the Federal
Register of September 7, 2023,
announcing a Notice of request for
information (RFI). The document
contained incorrect date in the DATES
section.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
ddrumheller on DSK120RN23PROD with NOTICES1
Carter A Roeber, Telephone number
(240) 276–1488, Email: Carter.Roeber@
samhsa.hhs.gov, or EBPRC@
samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of September
7, 2023, in FR Doc. 2023–19272, on
pages 61608 and 61609, in the second
column, correct the DATES caption to
read:
VerDate Sep<11>2014
17:03 Oct 13, 2023
Jkt 262001
Comments or feedback on this notice
must be received by end of business
day, November 7, 2023.
Dated: October 11, 2023.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2023–22792 Filed 10–13–23; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Extension and Expansion of
Declaration Zone Test
U.S. Customs and Border
Protection, DHS.
ACTION: General notice.
AGENCY:
On August 30, 2021, U.S.
Customs and Border Protection (CBP)
announced in the Federal Register that
CBP would conduct a Declaration Zone
test at cruise terminal facilities at
participating sea ports of entry (POEs)
that would run for approximately two
years. This document announces that
CBP is extending the test period for an
additional two years. In addition to the
extension, this document announces
that CBP intends to expand the
Declaration Zone test to up to eighteen
additional sea POEs, as well as to
travelers being processed in Simplified
Arrival for open loop cruises. The
Declaration Zone test allows for
streamlined processing by allowing a
demonstrative initial declaration for
arriving travelers in lieu of an oral or
written declaration of all articles
brought into the United States to a CBP
officer as required by current CBP
regulations.
DATES: CBP is extending the Declaration
Zone test at cruise terminal facilities at
participating sea POEs until October 16,
2025. CBP is expanding the Declaration
Zone test to eligible open loop cruises
no sooner than October 1, 2023. The
expansion date may vary at each
location.
ADDRESSES: Written comments
concerning program, policy, and
technical issues may be submitted at
any time during the test period via
email to BiometricSea@cbp.dhs.gov.
Please use ‘‘Comment on Declaration
Zone Test’’ in the subject line of the
email.
FOR FURTHER INFORMATION CONTACT:
Maria Rivera, Program Manager,
Biometric Entry-Exit Strategic
Transformation, Office of Field
Operations, maria.c.rivera@cbp.dhs.gov
or (202) 325–4596.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
Background
On August 30, 2021, U.S. Customs
and Border Protection (CBP) announced
in the Federal Register (86 FR 48436)
that CBP would conduct a Declaration
Zone test at cruise terminal facilities at
participating sea ports of entry (POEs).
The notice describes the Declaration
Zone test, while setting forth
requirements for participating in the
test, the duration of the test, and how
CBP will evaluate the test. The notice
also invites public comment on any
aspect of the test. In brief, the
Declaration Zone test fulfills the
declaration requirement under CBP
regulations, while also allowing for
streamlined processing. Current CBP
regulations require each traveler to
provide an oral or written declaration of
all articles brought into the United
States to a CBP officer. See 19 CFR part
148, subpart B. The Declaration Zone
test provides arriving travelers with an
alternative method to meet this
requirement by allowing a
demonstrative initial declaration
through the use of declaration zones at
cruise terminal facilities at select sea
POEs.
Description and Procedures
The 2021 notice provides the
description and procedures for the
Declaration Zone test. 86 FR 48437.
Within a cruise terminal facility
participating in the Declaration Zone
test, two distinct customs declaration
zone queues are established for entering
the egress area: one for No Items to
Declare and another for Items to
Declare. Signage is posted to clearly
label the queues at the entrance to the
egress area after travelers collect their
luggage. The physical act of selecting
the No Items to Declare queue or the
Items to Declare queue in and of itself
constitutes an initial demonstrative
declaration. CBP officers conduct roving
enforcement operations within the
baggage collection and egress area to
ensure traveler compliance.
No Items To Declare Queue
Travelers who determine they have
nothing to declare enter the No Items to
Declare queue and proceed through the
egress area to the facility exit. CBP
officers conduct roving operations in the
No Items to Declare zone to affirm
traveler compliance, receive oral
declarations, and make referrals to
secondary inspection as necessary.
Travelers who are not questioned by
CBP officers conducting roving
operations may proceed to the exit.
E:\FR\FM\16OCN1.SGM
16OCN1
]]>Agencies
[Federal Register Volume 88, Number 198 (Monday, October 16, 2023)]
[Notices]
[Pages 71371-71372]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22769]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AREA/REAP: Musculoskeletal, Oral, and Skin Sciences.
Date: November 7, 2023.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD
20892, (301) 496-8551, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Musculoskeletal, Rehabilitation and Skin
Sciences.
Date: November 7-8, 2023.
Time: 1:30 p.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD
20892, (301) 496-8551, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Chemistry, Biochemistry and Biophysics.
Date: November 8-9, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Pantazatos, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-2381,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurodevelopment and Plasticity.
Date: November 9, 2023.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vanessa S. Boyce, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 4185, MSC 7850, Bethesda, MD
20892, (301) 402-3726, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Research Enhancement Awards: Molecular Genetics, Cellular &
Cancer Biology.
Date: November 13, 2023.
Time: 1:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian Paul Chadwick, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3586,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Psychopathology.
Date: November 13, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stephanie Christine Nagle Emmens, Ph.D.,
Scientific Review Officer, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892,
(301) 594-6604, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Cell Biology, Developmental Biology, and
Bioengineering.
Date: November 14, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alexander Gubin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196, MSC 7812, Bethesda, MD
20892, 301-435-2902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery for Aging, Neurodegenerative
and Neurological Disorders.
Date: November 16-17, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Kathryn Partlow, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1016D,
[[Page 71372]]
Bethesda, MD 20892, (301) 594-2138, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery Involving the Nervous System.
Date: November 16-17, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lai Yee Leung, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1011D, Bethesda, MD 20892, (301) 827-8106,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 11, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-22769 Filed 10-13-23; 8:45 am]
BILLING CODE 4140-01-P
